Stock listing

Macrogenics, Inc.

Selected listing: A1W6ND · LS · EUR · DE

Macrogenics, Inc. (Lang & Schwarz: A1W6ND), Health Technology. Latest release Sep 9, 2026: MacroGenics to Participate in the H.C. Wainwright 28th Annual…

A1W6ND:LSEURDEUpdated October 2, 2026

Ticker: Lang & Schwarz: A1W6ND
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: Lang & Schwarz
Currency: EUR

About Macrogenics, Inc.

The company focuses on developing innovative therapies for cancer and other serious diseases. Macrogenics aims to advance its pipeline of biologic therapies to improve patient outcomes.

Latest news from Macrogenics, Inc.

MacroGenics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

September 9, 2026

MacroGenics Reports Second Quarter 2026 Financial Results, Streamlined Operating Model and Strengthened Financial Position

August 13, 2026

MacroGenics Announces Achievement of $10 Million Milestone Following Gilead’s Exercise of Option to License Preclinical Bispecific Program

August 11, 2026

MacroGenics Provides Clinical Update on Ongoing Phase 1 Study for MGC026

July 23, 2026

MacroGenics Completes Sale of GMP Manufacturing Operations to Bora Pharmaceuticals

July 1, 2026

All Macrogenics, Inc. news →

Events

Replays

MacroGenics, Inc. (MGNX) Q4 2024 Earnings Call
Thu, Mar 20, 2025 · 04:30 PM ET
Watch
MacroGenics, Inc. (MGNX) Q3 2024 Earnings Call
Tue, Nov 05, 2024 · 04:30 PM ET
Watch
MacroGenics, Inc. (MGNX) Q1 2024 Earnings Call
Thu, May 09, 2024 · 04:30 PM ET
Watch

Research Macrogenics, Inc.

Macrogenics, Inc. company profile

View the public company page for Macrogenics, Inc. on 6ix.

Macrogenics, Inc. news

Read company news and market updates connected to Macrogenics, Inc..

Macrogenics, Inc. investor events

Find investor webinars, events, and replay context for Macrogenics, Inc..